1. Home
  2. HCC vs HAE Comparison

HCC vs HAE Comparison

Compare HCC & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warrior Met Coal Inc.

HCC

Warrior Met Coal Inc.

SELL

Current Price

$89.46

Market Cap

5.2B

Sector

Energy

ML Signal

SELL

HAE

Haemonetics Corporation

HOLD

Current Price

$121.33

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCC
HAE
Founded
2015
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.8B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
HCC
HAE
Price
$89.46
$121.33
Analyst Decision
Buy
Buy
Analyst Count
7
11
Target Price
$109.17
★ $124.50
AVG Volume (30 Days)
554.2K
★ 620.2K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.03
0.72
Revenue
★ $1,310,043,000.00
$910,373,000.00
Revenue This Year
$52.73
$6.21
Revenue Next Year
$10.49
$5.54
P/E Ratio
★ $29.66
$168.90
Revenue Growth
N/A
★ N/A
52 Week Low
$61.87
$48.98
52 Week High
$111.42
$123.77

Technical Indicators

Market Signals
Indicator
HCC
HAE
Relative Strength Index (RSI) 45.19 73.84
Support Level $82.72 $100.92
Resistance Level $92.19 N/A
Average True Range (ATR) 3.19 3.29
MACD 0.24 1.22
Stochastic Oscillator 45.45 87.17

Price Performance

Historical Comparison
HCC
HAE

About HCC Warrior Met Coal Inc.

Warrior Met Coal Inc produces and exports met or steelmaking coal, which is used as a component for steel production by metal manufacturers in Europe, South America, and Asia. The company is involved in longwall mining operations in its underground mines based in Alabama, Mine No. 4, Mine No. 7, and Blue Creek. Additionally, its natural gas operations remove and sell natural gas from owned and leased coal seams by reducing natural gas levels in its mines. The company generates revenue mainly through the production of steelmaking coal for sale to the steel industry. Geographically, the firm generates maximum revenue from its customers in Asia, followed by Europe, South America, and the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: